390
Participants
Start Date
June 30, 2008
Primary Completion Date
May 31, 2017
Study Completion Date
May 31, 2017
cisplatinum or carboplatin and e.g.etoposide.
Standard chemotherapy treatment for patients with small cell lung cancer. Chemotherapy regimen contains a platinum drug and a topoisomerase inhibitor. Numbers of cycles 4-6 according to local variants. Used drugs=cisplatinum or carboplatin and e.g.etoposide. Treatment will be given every three weeks for 4-6 cycles according to local variants.
cisplatinum or carboplatin and e.g.etoposide+enoxaparin
Standard chemotherapy treatment for patients with small cell lung cancer. Chemotherapy regimen contains a platinum drug and a topoisomerase inhibitor. Numbers of cycles 4-6 according to local variants. In addition to this, subjects will receive daily subcutaneous injections of enoxaparin during chemotherapy treatment.
Gävle hospital, Gävle
Sahlgrenska University Hospital, Gothenburg
Helsingborg Hospital, Helsingborg
Ryhov Hospital, Jönköping, Jönköping
University Hospital, Örebro, Örebro
Norrlands University Hospital, Umeå
Blekinge Hospital, Karlskrona
Central Hospital, Karlstad
Central Hospital, Kristianstad
University Hospital Linköping, Linköping
University Hospital Department of Respiratory Medicine, Lund
University Hospital MAS, Malmo
Karolinska University Hospital, Stockholm
Akademiska hospital Uppsala, Uppsala
Central Hospital, Vaxjo
Ystad hospital, Ystad
Collaborators (1)
Sanofi
INDUSTRY
Lund University Hospital
OTHER